Yale Startups in Formation: Novel gene delivery modalities with Spark Therapeutics

HOST: James Boyle, Executive Director, Faculty Entrepreneurship & Venture Development

MODERATOR: Roy Herbst, MD, PhD: Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; Associate Cancer Center Director, Translational Science

FEATURED SPEAKER: Dr. Federico Mingozzi, the Chief Scientific Officer of Spark Therapeutics with discuss the novel gene delivery modalities. Dr. Mingozzi has had a distinguished career in gene therapy research, including as director of translational research at the Center for Cellular and Molecular Therapeutics, at Children’s Hospital of Philadelphia, where he was involved in the development of gene therapies based on the AAV vector platform. He serves as faculty at the Pierre and Marie Curie University in Paris and Universitat Autonoma de Barcelona, Spain.